Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05379673 · ClinicalTrials.gov registry record · NA
The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia
A NA study of Ventilatory Depression and Postoperative Respiratory Failure, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05379673 is a NA study of Ventilatory Depression and Postoperative Respiratory Failure that is actively recruiting participants, run by Stanford University. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05379673, a NA study of Ventilatory Depression and Postoperative Respiratory Failure, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
In this randomized-controlled trial the investigators will examine the effect of oxygen supplementation on the recovery of breathing for 90 minutes in the immediate post-anesthesia period starting from extubation of the trachea.
Conditions Studied
Interventions
- OTHER Oxygen Gas for Inhalation
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-10-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05379673
The ClinicalTrials.gov registry entry for NCT05379673 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ventilatory Depression appearing as the primary indexed condition, and to 1 intervention - of which Oxygen Gas for Inhalation is the first listed.
NCT05379673 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05379673 about?
NCT05379673 is a clinical study titled "The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia". In this randomized-controlled trial the investigators will examine the effect of oxygen supplementation on the recovery of breathing for 90 minutes in the immediate post-anesthesia period starting from extubation of the trachea.
What is the current status of trial NCT05379673?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-10-04. Estimated completion is 2026-12.
What conditions does trial NCT05379673 study?
This clinical trial studies the following conditions: Ventilatory Depression, Postoperative Respiratory Failure.
What interventions are being tested in trial NCT05379673?
The interventions under investigation include: Oxygen Gas for Inhalation (OTHER).
Who is sponsoring clinical trial NCT05379673?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05379673 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventilatory Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.